Académique Documents
Professionnel Documents
Culture Documents
Reimbursement Landscape - US
Released On 18th November 2015
Summary
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US report is an essential
source of information on and analysis of the healthcare, regulatory and reimbursement landscape in
the US. It identifies key trends in the countrys healthcare market and provides insights into its
demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most
importantly, the report provides valuable insights into the trends and segmentation of its
pharmaceutical and medical devices markets. It uses data and information sourced from proprietary
databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.
The population of the US in 2013 amounted to 316.1 million, having grown at a Compound Annual
Growth Rate (CAGR) of 0.8% from 2008. The countrys increasingly elderly population and
corresponding increase in the incidence of chronic diseases will help to boost the growth of the
pharmaceutical market, which was worth $326.9 billion in 2008, a value that is expected to have
reached $548.4 billion by 2020 at a CAGR of 4.4%. Approximately 86.6% of the US population
JSB Market Research Pvt. Ltd.
has healthcare coverage, which has helped to create an efficient healthcare system. New initiatives
taken by the Food and Drug Administration (FDA) have strengthened the review and approval
process. The value of the US medical device market was $116.2 billion in 2008, and is expected to
register a CAGR of 5.0% to reach an estimated $209.7 billion in 2020.
These growth trends can be primarily attributed to
- Sedentary lifestyles, leading to a high chronic disease burden
- High public healthcare expenditure by the Centers for Medicare and Medicaid Services (CMS)
- Increased R&D expenditure
- Easily accessible diagnostic technologies
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the
US, and includes - An overview of the pharmaceutical and medical device markets, including market size,
segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceuticals market: Pfizer, Merck,
Novartis, Sanofi and Abbott; and profiles and SWOT analyses of the major players in the medical
device market: Medtronic, DePuy, Siemens Healthcare, Abbott Laboratories, and Stryker
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of
the countrys healthcare reimbursement process, regulatory agencies and the approval processes for
new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators,
demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to JSB Market Research Pvt. Ltd.
- Develop business strategies by understanding the trends shaping and driving the US healthcare
market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical market segments, and companies likely to affect the US healthcare market in the
future
- Formulate effective sales and marketing strategies by understanding the competitive landscape
and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that
present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in the US healthcare
market
Table of Contents
1.1 List of Tables 11
1.2 List of Figures 15
2 Introduction 19
2.1 GlobalData Report Guidance 19
List of Tables
Table 1: Pharmaceutical Market*, US, Revenue ($bn), 2008-2013 24
Table 2: Pharmaceutical Market*, US, Revenue Forecast ($bn), 2014-2020 25
Table 3: Pharmaceutical Market, US, Exports and Imports ($bn), 2008-2013 26
Table 4: Drugs Going Off-Patent, Global, 2013-2014 30
Table 5: Pharmaceutical Market, US, Top Five Therapeutic Areas, Overview, 2012 33
JSB Market Research Pvt. Ltd.
Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual
Growth (%), 2013 36
Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 37
Table 8: Pharmaceutical Market, Merck, Global, Major Products, Revenue ($bn) and Annual
Growth (%), 2013 44
Table 9: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2014 45
Table 10: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual
Growth (%), 2013 52
Table 11: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018 53
Table 12: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013 62
Table 13: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 63
Table 14: Medical Device Market, US, Revenue ($bn), 2008-2013 76
Table 15: Medical Device Market, US, Revenue Forecast ($bn), 2014-2020 77
Table 16: Medical Device Market, US, Revenue by Segment, 2013 78
Table 17: Medical Device Market, US, Orthopedic Devices Market, Revenue ($bn), 2008-2013 80
Table 18: Medical Device Market, US, Orthopedic Devices Market, Sales Trends for Major
Players, 2012 81
Table 19: Medical Device Market, US, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013 82
Table 20: Medical Device Market, US, In Vitro Diagnostics Market, Sales Trends for Major
Players, 2012 83
Table 21: Medical Device Market, US, Cardiovascular Devices Market, Revenue ($bn), 2008-2013
84
Table 22: Medical Device Market, US, Cardiovascular Devices Market, Sales Trends for Major
Players, 2012 85
Table 23: Medical Device Market, US, Ophthalmic Devices Market, Revenue ($bn), 2008-2013 86
Table 24: Medical Device Market, US, Ophthalmic Devices Market, Sales Trends for Major
Players, 2012 87
Table 25: Medical Device Market, US, Healthcare IT Market ($bn), 2008-2013 88
Table 26: Medical Device Market, US, Healthcare IT Market, Sales Trends for Major Players, 2012
89
Table 27: Medical Device Market, US, Diagnostic Market, Revenue ($bn), 2008-2013 90
Table 28: Medical Device Market, US, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 91
Table 29: Medical Device Market, US, Major Medical Device Companies Revenue, 2012 92
Table 30: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2013 94
Table 31: Medical Device Market, Abbott, Global, Major Products, 2014 114
Table 32: Medical Device Market, Abbott, Global, Late-Stage Pipeline, 2014 115
JSB Market Research Pvt. Ltd.
Table 33: Total Medicare Income, US, Expenditure and Trust Fund Assets ($bn), 20082023 138
Table 34: Market Access, US, Poverty Guidelines, 2014 142
Table 35: Market Access, US, Metal Plans, 2014 143
Table 36: Market Access, US, Coverage by Type of Health Insurance (%), 2013 143
Table 37: Healthcare Spending, US, Out-of-Pocket Expenditure (%), 2008-2013 144
Table 38: Market Access, US, Annual Price Change (%), 2008-2013 145
Table 39: Market Access, US, Clinical Trial Phases, 2014 154
Table 40: Economic Landscape, US, American Jobs Act, Cost ($bn), 2011 194
Table 41: Economic Landscape, US, Major Payments ($bn), 2013 196
Table 42: Economic Indicators, US, GDP per Capita ($), 2008-2013 198
Table 43: Economic Indicators, US, GDP per Capita Forecast ($), 2014-2020 199
Table 44: Economic Indicators, US, GDP Annual Growth (%), 2008-2013 200
Table 45: Economic Indicators, US, GDP Annual Growth Forecast (%), 2014-2020 201
Table 46: Economic Indicators, US, Gross National Income per Capita ($bn), 2008-2013 202
Table 47: Economic Indicators, US, Average Consumer Price Index, 2008-2013 203
Table 48: Economic Indicators, US, Average Consumer Price Index Forecast, 2014-2020 204
Table 49: Economic Indicators, US, Average Consumer Price Annual Change (%), 2008-2013 205
Table 50: Economic Indicators, US, Currency Exchange Rate (JPY/$), 2008-2013 206
Table 51: Economic Indicators, US, Currency Exchange Rate (/$), 2008-2013 207
Table 52: Economic Indicators, US, Currency Exchange Rate (/$), 2008-2013 208
Table 53: Economic Indicators, US, Foreign Direct Investment ($bn), 2008-2013 209
Table 54: Economic Indicators, US, Foreign Exchange Reserves ($bn), 2008-2013 210
Table 55: Economic Indicators, US, Trade of Goods ($bn), 2008-2013 211
Table 56: Economic Indicators, US, Trade of Services ($bn), 2008-2013 212
Table 57: Economic Indicators, US, Imports of Goods and Services ($bn), 2008-2013 213
Table 58: Economic Indicators, US, Exports of Goods and Services ($bn), 2008-2013 214
Table 59: Economic Indicators, US, Government Structural Balance ($bn), 2008-2013 216
Table 60: Economic Indicators, US, Government Structural Balance Forecast ($bn), 2014-2020 216
Table 61: Economic Indicators, US, General Government Net Debt ($tr), 2008-2013 218
Table 62: Economic Indicators, US, General Government Net Debt Forecast ($tr), 2014-2020 218
Table 63: Economic Indicators, US, Major Industries, GDP ($tr), 2013 221
Table 64: Demographics, US, Population (million), 2008-2013 222
Table 65: Demographics, US, Population Forecast (million), 2014-2020 223
Table 66: Demographics, US, Population, Urban and Rural Population (%), 2008-2013 224
Table 67: Demographics, US, Population Distribution by Age Group (%), 2008-2013 225
Table 68: Demographics, US, Population Distribution by Age Group Forecast (%), 2014-2020 226
JSB Market Research Pvt. Ltd.
Table 69: Demographics, US, Births (per 1,000 Population), 2008-2013 227
Table 70: Demographics, US, Mortality (per 1,000 Population), 2008-2013 228
Table 71: Demographics, US, Major Causes of Mortality (000), 2011 230
Table 72: Demographics, US, Children 5 Years, Mortality Rate (per 1,000 Live Births), 20082013 231
Table 73: Demographics, US, Immunization Rate (%), 2008-2013 232
Table 74: Demographics, US, Major Causes of Male Mortality (000), 2011 233
Table 75: Demographics, US, Major Causes of Female Mortality (000), 2011 235
Table 76: Demographics, US, Gender Ratio (M/F), 2008-2013 236
Table 77: Demographics, US, Life Expectancy at Birth (Years), 2008-2013 237
Table 78: Demographics, US, Student Enrollment by Level of Education (%), 2013 239
Table 79: Demographics, US, Unemployment Rate (%), 2008-2013 240
Table 80: Demographics, US, Major Diseases, DALYs (per 100,000 Population), 2004 242
Table 81: Healthcare Infrastructure, US, Hospitals, 2008-2013 243
Table 82: Healthcare Infrastructure, US, Federal and Non-federal Hospitals, 2008-2013 244
Table 83: Healthcare Infrastructure, US, Diagnostic Equipment (per Million Population), 20082013 245
Table 84: Healthcare Infrastructure, US, Hospital Beds (per 1,000 Population), 2008-2013 247
Table 85: Healthcare Infrastructure, US, Doctors (per 1,000 Population), 2008-2013 248
Table 86: Healthcare Infrastructure, US, CO2 Emissions (Million Metric Tons), 2008-2013 249
Table 87: Healthcare Infrastructure, US, N2O Emissions (Million Metric Tons), 2008-2013 250
Table 88: Healthcare Infrastructure, US, PM10 Emissions (g/m3), 2008-2013 251
Table 89: Healthcare Infrastructure, US, Nurses (per 1,000 Population), 2008-2013 252
Table 90: Healthcare Infrastructure, US, Pharmacists (per 1,000 Population), 2008-2013 253
Table 91: Healthcare Infrastructure, US, Dentists (per 1,000 Population), 2008-2013 254
Table 92: Healthcare Expenditure, US, Healthcare Expenditure (% of GDP), 2008-2013 256
Table 93: Healthcare Expenditure, US, Healthcare Expenditure, Share of Major Components (%),
2012 257
Table 94: Healthcare Expenditure, US, Healthcare Expenditure, Public-Private Share (%), 20082013 258
Table 95: Healthcare Expenditure, US, Research and Development Expenditure ($bn), 2008-2013
259
Table 96: Trade Fairs, US, Major Healthcare Trade Fairs, 2015 263
List of Figures
Figure 1: Pharmaceutical Market*, US, Revenue ($bn), 2008-2013 24
Figure 2: Pharmaceutical Market*, US, Revenue Forecast ($bn), 2014-2020 25
Figure 3: Pharmaceutical Market, US, Exports and Imports ($bn), 2008-2013 26
Figure 4: Pharmaceutical Distribution Channels, US, 2011 28
Figure 5: Pharmaceutical Market, US, Top Five Therapeutic Areas, Pharmaceutical Expenditure
($bn), 2012 32
Figure 6: Medical Device Market, US, Revenue ($bn), 2008-2013 76
Figure 7: Medical Device Market, US, Revenue Forecast ($bn), 2014-2020 77
Figure 8: Medical Device Market, US, Revenue by Segment ($bn), 2013 78
Figure 9: Medical Device Market, US, Orthopedic Devices Market, Revenue ($bn), 2008-2013 80
Figure 10: Medical Device Market, US, Orthopedic Devices Market, Sales Trends for Major
Players, 2008-2012 81
Figure 11: Medical Device Market, US, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013 82
Figure 12: Medical Device Market, US, In Vitro Diagnostics Market, Sales Trends for Major
Players, 2008-2012 83
Figure 13: Medical Device Market, US, Cardiovascular Devices Market, Revenue ($bn), 20082013 84
Figure 14: Medical Device Market, US, Cardiovascular Devices Market, Sales Trends for Major
Players, 2008-2012 85
Figure 15: Medical Device Market, US, Ophthalmic Devices Market, Revenue ($bn), 2008-2013 86
Figure 16: Medical Device Market, US, Ophthalmic Devices Market, Sales Trends for Major
Players, 2008-2012 87
Figure 17: Medical Device Market, US, Healthcare IT Market, Revenue ($bn), 2008-2013 88
Figure 18: Medical Device Market, US, Healthcare IT Market, Sales Trends for Major Players,
2008-2012 89
Figure 19: Medical Device Market, US, Diagnostic Market, Revenue ($bn), 2008-2013 90
Figure 20: Medical Device Market, US, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 91
Figure 21: Medical Device Market, US, Major Medical Device Companies Revenue ($bn), 2012 92
Figure 22: Healthcare Market, US, Drivers and Barriers, 2014 129
Figure 23: Healthcare Spending, US, Out-of-Pocket Expenditure (%), 2008-2013 144
Figure 24: Market Access, US, Annual Price Change (%), 2008-2013 145
Figure 25: Market Access, US, Structure of Food and Drug Administration, 2014 148
Figure 26: Market Access, US, Outline of the Clinical Development Process for a New Drug, 2012
155
JSB Market Research Pvt. Ltd.
Figure 27: Market Access, US, Medical Device Approval Process, 2014 158
Figure 28: Market Access, US, Registration Fees for Medical Devices, 2013-2017 163
Figure 29: Market Access, US, Patent Approval Process, 2013 172
Figure 30: Economic Indicators, US, GDP per Capita ($), 2008-2013 198
Figure 31: Economic Indicators, US, GDP per Capita Forecast ($), 2014-2020 199
Figure 32: Economic Indicators, US, GDP Annual Growth (%), 2008-2013 200
Figure 33: Economic Indicators, US, GDP Annual Growth Forecast (%), 2014-2020 201
Figure 34: Economic Indicators, US, Gross National Income per Capita ($tr), 2008-2013 202
Figure 35: Economic Indicators, US, Average Consumer Price Index, 2008-2013 203
Figure 36: Economic Indicators, US, Average Consumer Price Index Forecast, 2014-2020 204
Figure 37: Economic Indicators, US, Average Consumer Price Annual Change (%), 2008-2013 205
Figure 38: Economic Indicators, US, Currency Exchange Rate (JPY/$), 2008-2013 206
Figure 39: Economic Indicators, US, Currency Exchange Rate (/$), 2008-2013 207
Figure 40: Economic Indicators, US, Currency Exchange Rate (/$), 2008-2013 208
Figure 41: Economic Indicators, US, Foreign Direct Investment ($bn), 2008-2013 209
Figure 42: Economic Indicators, US, Foreign Exchange Reserves ($bn), 2008-2013 210
Figure 43: Economic Indicators, US, Trade of Goods ($bn), 2008-2013 211
Figure 44: Economic Indicators, US, Trade of Services ($bn), 2008-2013 212
Figure 45: Economic Indicators, US, Imports of Goods and Services ($bn), 2008-2013 213
Figure 46: Economic Indicators, US, Exports of Goods and Services ($bn), 2008-2013 214
Figure 47: Economic Indicators, US, Government Structural Balance ($bn), 2008-2013 215
Figure 48: Economic Indicators, US, Government Structural Balance Forecast ($bn), 2014-2020
216
Figure 49: Economic Indicators, US, General Government Net Debt ($tr), 2008-2013 217
Figure 50: Economic Indicators, US, General Government Net Debt Forecast ($tr), 2014-2020 218
Figure 51: Economic Indicators, US, Major Industries, GDP ($tr), 2014 220
Figure 52: Demographics, US, Population (million), 2008-2013 222
Figure 53: Demographics, US, Population Forecast (million), 2014-2020 223
Figure 54: Demographics, US, Population, Urban and Rural Population (%), 2008-2013 224
Figure 55: Demographics, US, Population Distribution by Age Group (%), 2008-2013 225
Figure 56: Demographics, US, Population Distribution by Age Group Forecast (%), 2014-2020 226
Figure 57: Demographics, US, Births (per 1,000 Population), 2008-2013 227
Figure 58: Demographics, US, Mortality (per 1,000 Population), 2008-2013 228
Figure 59: Demographics, US, Major Causes of Mortality (000), 2011 229
Figure 60: Demographics, US, Children 5 Years, Mortality Rate (per 1,000 Live Births), 20082013 231
JSB Market Research Pvt. Ltd.
Product Price:
License Type
Price
$ 1995
Site Licence
$ 3990
$ 5985
Related reports:
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details
at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stopshop for all information related to market research for any sector of the industry. Along with
providing in-depth analysis though reports, JSB market research also provides regular updates of
the market though newsletters. Our reports are a well-researched work of market researchers with
an extensive knowledge and a good level of market experience.
To know more on CountryFocus: Healthcare, Regulatory and Reimbursement Landscape US
http://www.jsbmarketresearch.com/healthcare-medical/r-countryfocus-healthcareregulatory-and-reimbursement-landscape-us-167622